Impact of Drusen Volume on Quantitative Fundus Autofluorescence in Early and Intermediate Age-Related Macular Degeneration.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 05 2019
Historique:
entrez: 4 5 2019
pubmed: 6 5 2019
medline: 11 10 2019
Statut: ppublish

Résumé

Drusen volume (DV) and quantitative autofluorescence (qAF) are potential indicators of progression in age-related macular degeneration (AMD). This prospective and observational study examined the association between DV and qAF of the retinal pigment epithelium. Eighty-eight eyes of 52 patients with early and intermediate AMD were included. The mean follow-up was 9.2 ± 5.6 months, resulting in 312 examinations. DV was extracted from 6 × 6-mm spectral-domain optical coherence tomography scans. qAF was measured using a rotated Delori pattern. The associations between qAF and DV, age, sex, and lens status were investigated using linear mixed models. Patients' mean age was 75.6 ± 5.0 years (range, 61.0-83.4 years). Sixty-eight eyes (77.3%) were from females. No significant association between DV and qAF was found, neither within the total outer Early Treatment Diabetic Retinopathy Study (ETDRS) grid nor for ETDRS segments six to nine (all P > 0.05). Sex and lens status were not associated with qAF (P = 0.429 and P = 0.213, respectively). A significant association between age and qAF (P = 0.025) was found, indicating a decrease of qAF with age. Quantification of DV and fundus autofluorescence did not reveal any correlation in early and intermediate AMD. qAF decreased with age, whereas DV increased in about half of the patients. This finding is a quantitative corroboration that fundus autofluorescence and the buildup of drusen are not correlated processes in AMD.

Identifiants

pubmed: 31050721
pii: 2733080
doi: 10.1167/iovs.19-26566
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1937-1942

Auteurs

Gregor Sebastian Reiter (GS)

Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Reinhard Told (R)

Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Ferdinand Georg Schlanitz (FG)

Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Hrvoje Bogunovic (H)

Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Lukas Baumann (L)

Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Stefan Sacu (S)

Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Ursula Schmidt-Erfurth (U)

Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Andreas Pollreisz (A)

Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH